Skip to main content
Matthias H. Tschöp
Matthias Tunger Photodesign

Prof. Dr. med. Dr. h.c. Matthias H. Tschöp

CEO at Helmholtz Munich

"My vision is centered on transformative acceleration from basic research breakthroughs to medical solutions for society."

˝My strategic vision is centered on transformative acceleration of the path from basic research breakthroughs to delivering medical solutions for society.˝


Matthias H. Tschöp is the CEO and Spokesperson for the Management at Helmholtz Munich since 2018 and ‘Alexander von Humboldt’ Professor at the Technical University of Munich since 2012. His vision is to position the region Munich as a world leading hub for biomedical research in order to efficiently find new solutions to the health challenges facing our rapidly changing world. He is realizing this by advancing excellence in basic biomedical research and accelerates its translation into personalized prevention and new precision therapies.

Matthias Tschöp (*1967), the physician, scientist and science manager, has made pioneering discoveries in the diabetes and obesity research fields. His achievements include the discovery of the hunger hormone ghrelin as well as the discovery of gut hormone polyagonists, a group of active agents that can significantly improve weight reduction in obesity as well as blood sugar control in type 2 diabetes. The drug Tirzepatide (Mounjaro), produced by Lilly, was the first polyagonist, which was approved for use back in May 2022 (previously in the USA) and another 10 polyagonists are on their way to approval in clinical trials.  

Born in Munich and a family man, he knows the different perspectives between medicine and research from his own experience: After obtaining his license to practice medicine from the Ludwig Maximilian University Hospital, he moved to the United States to work in diabetes research for a pharmaceutical company, co-founded a start-up and headed a research institute at the University of Cincinnati as a professor and research director before returning to Germany after more than ten years abroad. He turned the Helmholtz Diabetes Center into a world-leading research institution as its founding director and launched the Helmholtz Pioneer Campus before he joined the executive board.

Facts and Figures


Member of the European Molecular Biology Organization


CEO at Helmholtz Munich


Full member of the Bavarian Academy of Sciences and Humanities


Honorary Doctor of the University of Leipzig


Member of the Academia Europaea


Member of the Leopoldina


Alexander von Humboldt Professor at the Technical University of Munich


Director Helmholtz Diabetes Center at Helmholtz Munich


Professorship at the University of Cincinnati


Doctorate in Medicine at the Ludwig-Maximilians-Univeristät München

Selected Awards

  • 2023: Banting Medal for Scientific Achievement

  • 2021: Ernst Jung Prize for Medicine

  • 2021: Berthold Medal

  • 2019: Paul Langerhans Medal

  • 2017: Carus Medal of the National Academy of Sciences Leopoldina

  • 2016: European Medal of the Society for Endocrinology

  • 2014: Erwin Schrödinger Prize

Gold Star Awards Luxury Background
suppa -

Matthias H. Tschöp Receives Ernst Jung Prize for Medicine 2021

With your consent, third party content may be loaded here, which could use cookies from the respective provider. By using this content, you agree to the use of cookies.
Helmholtz Munich has no influence on advertising content that is displayed before, during or after Helmholtz Munich videos. We do not assume any liability for these contents. Find more information here.

Twitter feed